R1 RCM Inc (NASDAQ:RCM) has received an average recommendation of “Buy” from the eight analysts that are currently covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $11.75.
A number of equities analysts recently commented on the stock. Zacks Investment Research raised shares of R1 RCM from a “sell” rating to a “hold” rating in a research report on Wednesday, October 10th. BidaskClub raised shares of R1 RCM from a “hold” rating to a “buy” rating in a report on Thursday, August 30th. Cantor Fitzgerald raised their target price on shares of R1 RCM from $10.00 to $11.00 and gave the company an “overweight” rating in a report on Friday, August 10th. TheStreet raised shares of R1 RCM from a “d+” rating to a “c” rating in a report on Tuesday, September 4th. Finally, Chardan Capital initiated coverage on shares of R1 RCM in a report on Tuesday, September 4th. They issued a “buy” rating and a $17.00 target price on the stock.
NASDAQ:RCM traded down $0.03 during mid-day trading on Friday, reaching $8.67. 1,038,707 shares of the company’s stock were exchanged, compared to its average volume of 600,351. R1 RCM has a one year low of $3.56 and a one year high of $11.00. The firm has a market cap of $956.85 million, a price-to-earnings ratio of -19.70 and a beta of -0.76. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.08 and a current ratio of 1.08.
In other news, Director Albert Rene Zimmerli bought 10,000 shares of the firm’s stock in a transaction on Thursday, September 6th. The shares were purchased at an average cost of $9.73 per share, with a total value of $97,300.00. Following the acquisition, the director now directly owns 10,000 shares in the company, valued at $97,300. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. 59.40% of the stock is owned by company insiders.
Several institutional investors have recently made changes to their positions in the stock. Oppenheimer Asset Management Inc. bought a new stake in shares of R1 RCM during the 3rd quarter valued at approximately $126,000. Russell Investments Group Ltd. grew its holdings in shares of R1 RCM by 36.6% during the 3rd quarter. Russell Investments Group Ltd. now owns 531,555 shares of the financial services provider’s stock valued at $5,392,000 after purchasing an additional 142,531 shares during the last quarter. Unterberg Capital LLC grew its holdings in shares of R1 RCM by 10.0% during the 3rd quarter. Unterberg Capital LLC now owns 550,000 shares of the financial services provider’s stock valued at $5,588,000 after purchasing an additional 50,000 shares during the last quarter. Northern Trust Corp grew its holdings in shares of R1 RCM by 8.2% during the 2nd quarter. Northern Trust Corp now owns 1,181,569 shares of the financial services provider’s stock valued at $10,256,000 after purchasing an additional 89,116 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in shares of R1 RCM by 20.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 390,447 shares of the financial services provider’s stock valued at $3,389,000 after purchasing an additional 66,099 shares during the last quarter. 49.75% of the stock is currently owned by institutional investors.
R1 RCM Company Profile
R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.
Further Reading: Return on Investment (ROI) Defined, Explained
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.